HOME
ABOUT
R&D
Science & platform
Pipeline
PUBLICATION
NEWS/IR
CONTACT US

PUBLICATION

publication
Research articles and posters
September 2022

MYC amplification-conferred primary resistance to capmatinib in a MET-amplified NSCLC patient: a case report

Transl Lung Cancer Res. 2022 Sep;11(9):1967-1972. doi: 10.21037/tlcr-22-176. PMID: 36248327; PMCID: PMC9554684.
March 2020

Docetaxel-resistant prostate cancer cells become sensitive to gemcitabine due to the upregulation of ABCB1

Prostate. 2020 May;80(6):453-462. doi: 10.1002/pros.23946. Epub 2020 Mar 5. PMID: 32134535.
February 2019

Structural assignment of the enol-keto tautomers of one-pot synthesized 4-hydroxyquinolines/4-quinolones

Org Chem Front 2018 Nov 28; 6:183–189. https://doi.org/10.1039/c8qo00884a
January 2018

One-pot sequential synthesis of tetrasubstituted thiophenes via sulfur ylide-like intermediates

J Org Chem. 2018 Jan 26;14:243-252. doi: 10.3762/bjoc.14.16. PMID: 29441144; PMCID: PMC5789428.
June 2017

Establishment and application of bladder cancer patient-derived xenografts as a novel preclinical platform

Transl Cancer Res 2017 June;6(Suppl 4):S733-S743. doi: 10.21037/tcr.2017.06.27
July 2017

The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression

Oncotarget. 2016 Jul 22;8(31):50500-50509. doi: 10.18632/oncotarget.10784. PMID: 28881578; PMCID: PMC5584157.
December 2015

Regulation of cancer cell death by a novel compound, C604, in a c-Myc-overexpressing cellular environment

J Pharmacol. 2015 Dec 15;769:257-65. doi: 10.1016/j.ejphar.2015.11.027. Epub 2015 Nov 25. PMID: 26607468.
February 2014

Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth

J Urol. 2014 Feb;191(2):510-8. doi: 10.1016/j.juro.2013.07.019. Epub 2013 Jul 17. PMID: 23872029.
January 2014

Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer

Oncotarget. 2014 Jan 30;5(2):326-37. doi: 10.18632/oncotarget.1545. PMID: 24504118; PMCID: PMC3964210.
August 2010

Small-molecule inhibitors of c-Myc transcriptional factor suppress proliferation and induce apoptosis of promyelocytic leukemia cell via cell cycle arrest.

Mol Biosyst. 2010 Aug;6(8):1503-9. doi: 10.1039/c002534h. Epub 2010 May 18. PMID: 20485733.
Januaray 2006

Fatty acids, inhibitors for the DNA binding of c-Myc/Max dimer, suppress proliferation and induce apoptosis of differentiated HL-60 human leukemia cell

Leukemia. 2006 Jan;20(1):122-7. doi: 10.1038/sj.leu.2404022. PMID: 16281068.
November 2005

Momordin I, an inhibitor of AP-1, suppressed osteoclastogenesis through inhibition of NF-kappaB and AP-1 and also reduced osteoclast activity and survival

Biochem Biophys Res Commun. 2005 Nov 25;337(3):815-23. doi: 10.1016/j.bbrc.2005.09.113. Epub 2005 Sep 28. PMID: 16213465.
September 2005

Negative regulation of beta-catenin/Tcf signaling by naringenin in AGS gastric cancer cell

Biochem Biophys Res Commun. 2005 Sep 30;335(3):771-6. doi: 10.1016/j.bbrc.2005.07.146. PMID: 16102728.
August 2005

Determination of the dissociation constants for recombinant c-Myc, Max, and DNA complexes: the inhibitory effect of linoleic acid on the DNA-binding step

Biochem Biophys Res Commun. 2005 Aug 19;334(1):269-75. doi: 10.1016/j.bbrc.2005.06.088. PMID: 16002048.
February 2004

Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding

Biochim Biophys Acta. 2004 Feb 24;1670(3):217-28. doi: 10.1016/j.bbagen.2003.12.007. PMID: 14980448.
TOP
검색 닫기